InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Staab Thomas R II, Chief Financial Officer. Insider active across 3 companies, notably Tenax Therapeutics, INC.. Cumulatively, 15 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €6k. Activity tracked since 11 January 2022. The latest transaction was disclosed on 11 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Staab Thomas R II
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
10,000 shares0Common StockSEC:0001193125-26-221926:0
5,500 shares@ US$2.6525.7% of flowCommon StockSEC:0001193125-26-116117:0
1,076 shares@ US$11.3213.2% of flowCommon StockSEC:0001193125-26-061464:0
1,826 shares@ US$11.5723.3% of flowCommon StockSEC:0001193125-26-011796:0
12,766 shares0Common StockSEC:0000950170-25-024336:0
1,839 shares@ US$8.2540.0% of flowCommon StockSEC:0000950170-25-015541:0
3,500 shares@ US$2.6523.1% of flowCommon StockSEC:0000950170-24-095487:0
1,853 shares@ US$4.4320.3% of flowCommon StockSEC:0000950170-24-055774:0
6,656 shares0Common StockSEC:0000899243-23-001798:0
2,025 shares@ US$3.16216.6% of flowCommon StockSEC:0000899243-22-037965:0
Canonical exit: 6 Mar 2023 (T+90)
15,000 shares0Common StockSEC:0000899243-22-001924:0
4,823 sharesCommon StockSEC:0001127602-16-037574:0
2,500 sharesCommon StockSEC:0001127602-16-037469:0
12,500 sharesCommon StockSEC:0001127602-16-037469:1
1,676 sharesCommon StockSEC:0001127602-16-035651:0
15 of 15 declarations
About Staab Thomas R II
Thomas R. Staab II is the Chief Financial Officer at Tenax Therapeutics, Inc. and LENSAR, Inc. He oversees the financial and strategic operations of both companies. His role is crucial in ensuring their financial health and supporting their growth in the market.
